We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advisory Council on the Misuse of Drugs’ report on the synthetic opioid known as MT-45.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Using data and technology to transform outcomes for patients and citizens.
Report to Lynne Featherstone in response to Norman Baker's request for advice on whether opioid substitution therapy should be time limited.
Home Office evidence review (2014) on new psychoactive substances in England, which informed the new psychoactive substances review by an expert panel.
Government's response to the recommendations and advice made by the expert panel reviewing the UK’s response to new psychoactive substances.
Report on the 2013 to 2014 international comparators study of approaches to drug-related issues by the UK and other countries. This is a supporting document to the 2010 drug strategy.
Report looks into the effectiveness and issues of the UK’s current legislative and operational response to NPS and the ongoing challenges.
Sets out national waiting time standards from April 2015 and plans to provide better access to mental health services over the next 5 years.
Response setting out a system-wide programme of work to implement the Mental Capacity Act 2005.
MHRA is asking for feedback on a proposal to simplify the information requirements for advertisements aimed at prescribers and suppliers of medicines.
Government response to the Health Select Committee’s report into the care, treatment and support of those with long term conditions.
Seeking views on the draft physical activity implementation document 'Everybody Active, Every Day' and supporting implementation and evidence guide.
PHE is developing a guide to sexual and reproductive health and HIV commissioning, focused on how to pull the whole system together.
This consultation is on proposals to amend the Human Medicines Regulations 2012 to allow the supply of salbutamol asthma inhalers to be kept in schools for emergency use.
Public Health England's role in a radiological or nuclear emergency.
PHE consultation response sets out latest evidence on the impact of standardised packaging of tobacco products.
MHRA seeks views on the listing of prescription medicines exempted from the safety feature and non-prescription medicines that must bear the safety feature (MLX387).
Asks for views on whether clarifying the law will encourage doctors to develop innovative treatments in a responsible way.
Seeks views on draft regulations on the use of new techniques to prevent mothers passing serious mitochondrial diseases to their children.
What the government is doing to meet the challenges of an ageing population.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).